The Fund announced that its Board of Directors (the “Board”) has approved a cash tender offer to purchase up to 10% of the Fund’s outstanding shares.

This tender offer is being conducted pursuant to the Fund’s previously announced Conditional Tender Offer (the “CTO”). The conditions of the CTO were satisfied as the average trading discount of the Fund’s shares exceeded 9% during the period from July 1, 2025 through March 31, 2026 (the “Measurement Period”). The Fund’s average trading discount during the Measurement Period was 10.5%.

Following a meeting of the Board scheduled for late May 2026, the Fund expects to announce additional regarding the tender offer, including the anticipated commencement date and other material terms and conditions, as appropriate.